NCT06282783 Studying Topiramate for Re-Activating the HIV-1 Reservoir Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT06247527 Psychoeducation, Relaxation, PrOblem Solving, Activation, Cognitive Coping Therapy for Adolescents and Youth in HIV Care Status NOT_YET_RECRUITING Phase NA
NCT06205602 Antiretrovirals Combined With Antibodies for HIV-1 Cure In Africa Status RECRUITING Phase PHASE2
NCT06203132 DORAvirine Versus DOlutegravir Based Antiretroviral Regimens in Treatment-naïve People Living With HIV-1 Infection Status RECRUITING Phase PHASE3
NCT06127290 HIV Resistance, Molecular Epidemiology and New Treatment Strategies in the Eastern European Region and in Russia Status RECRUITING Phase N/A
NCT06104306 Study of B/F/TAF in Participants Switching From CAB + RPV to B/F/TAF for HIV-1 Infection (EMPOWER) Status COMPLETED Phase PHASE4
NCT06071767 Evaluation of Safety, Immunogenicity and Efficacy of a Triple Immune Regimen in Adults Initiated on ART During Acute HIV-1 Status RECRUITING Phase PHASE1/PHASE2
NCT06031272 Pausing Antiretroviral Treatment Under Structured Evaluation Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06022406 Fecal Microbiota Translantation (FMT) to Reduce Inflammation in PLWH: The Gutsy Pilot Study Status COMPLETED Phase PHASE2
NCT05998499 HIV-Infected Latin American Asylum Seekers in Europe: Insights From the EuroLatin HIV Cohort Status COMPLETED Phase N/A
NCT05973825 Immuno-virological Evaluation of Persons Living With HIV (PLWH) Status NOT_YET_RECRUITING Phase NA
NCT05924438 A Randomised, Phase 3 Non-inferiority Study of DOR/3TC/TDF Compared to DTG/TAF/FTC in Participants Infected With HIV-1 Starting First-line Antiretroviral Therapy Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05896852 Healthy Lifestyles: A Home Based Physical Activity Intervention in Persons Living With HIV Status ACTIVE_NOT_RECRUITING Phase NA
NCT05890963 10E8.4/iMab Bispecific Antibody and VRC07-523LS Monoclonal Antibody in HIV-infected Adults Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05828095 A Clinical Trial to Evaluate the Safety and Immunogenicity of Synthetic DNAs Encoding a Native-like HIV Env Trimer and Interleukin-12 (INO-6160), Alone or in a Prime-boost Regimen With 3M-052-AF + Alum Adjuvanted VRC HIV Env Trimer 4571 in Adult Participants Without HIV Status COMPLETED Phase PHASE1
NCT05769569 Safety and Efficacy of Neutralizing Antibodies and Vaccination for Induction of HIV Remission Status WITHDRAWN Phase PHASE1
NCT05700630 Ph1 Study of FT538 Alone and With Vorinostat for Persistent Low-Level HIV Viremia Status WITHDRAWN Phase PHASE1